DEVELOPING DIGITAL HEALTHCARE ECOSYSTEM BUSINESS IN PHARMACEUTICALS HOLDING COMPANY

• Main Author: Zakaria Ash-Sholih Zain, Zaki
• Format: Theses
• Language: Indonesia
• Subjects: Manajemen umum
• Online Access: https://digilib.itb.ac.id/gdl/view/72873
• Institution: Institut Teknologi Bandung

SOE Pharmaceuticals Holding Company increases competitiveness in the pharmaceutical and healthcare industries. Digitally integrating the strengths and focuses of SOE Pharmaceuticals Holding Company could establish an end-to-end healthcare business ecosystem. The holding company for the pharmaceutical industry should encourage drug development and distribution. SOE Pharmaceuticals Holding Company will support Indonesia in constructing a healthcare holding from its foundation. Building a digital healthcare business ecosystem is complex due to the diverse organizational structures of SOE Pharmaceuticals Holding Company members. Although SOE Pharmaceuticals Holding Company companies share product portfolios, their value chains are distinct. Integration of the Bio Farma, Indofarma, and Kimia Farma ecosystems is still being determined. Prior to the formation of the SOE Pharmaceuticals Holding Company, each company already possessed a digital platform. These digital platforms use analogous operational and commercial activity but utilize distinct platform products. Consequently, they must be integrated with effort. Data administration and analysis are still separated at the subsidiary company level and have yet to be incorporated into the SOE Pharmaceuticals Holding Company ecosystem. Healthcare ecosystem support capabilities and innovations are constrained due to a lack of optimization in marketing tech-stack investments. Despite the advantages of traditional channels (such as hospitals and wholesalers), SOE Pharmaceuticals Holding Company is still not present in current channels. Although SOE Pharmaceuticals Holding Company has a complete value chain and product portfolio to meet public needs, numerous product lines overlap. As a result, rather than fostering synergy, this condition forces enterprises with comparable product lines to compete in the same market. Due to the lack of a collaboration scheme and capacities for healthcare services in health facilities, the collaborative management system connected with the value chain of healthcare facilities has yet to be developed. All organizational lines demand improvement in organization, digital talent, business processes, and cost management, particularly in process harmonization and integration along the value chain. Drawing from a comprehensive analysis of the current business situation, SOE Pharmaceuticals Holding Company must undertake a series of strategic initiatives to establish a digital healthcare ecosystem business which can enhance its competitive advantage. The strategic initiatives referred to are intended to be implemented within the near to intermediate future, expecting to result in an advantageous outcome given the present circumstances. To successfully implement the proposed ecosystem, it is imperative to transition from an existing business model to a digital healthcare ecosystem business model. Therefore, SOE Pharmaceuticals Holding Company can effectively and efficiently implement the digital healthcare business to achieve the expected competitive advantage.